Arcadia Biosciences Inc.

3.19
0.20 (6.77%)
At close: Apr 24, 2025, 3:59 PM
3.25
1.88%
After-hours: Apr 24, 2025, 07:15 PM EDT

Arcadia Biosciences Revenue Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Sep 30, 2018 Jun 30, 2018
Product Revenue 1.54M 1.31M 1.25M 1.38M 1.51M 993K 1.85M 2.95M 3.17M 2.08M 2.32M 1.38M 803K 414K 245K 231K 154K 329K 216K 162K 107K 144K 188K
Product Revenue Growth +17.69% +4.06% -8.99% -8.61% +51.96% -46.35% -37.17% -7.07% +52.33% -10.46% +68.53% +71.73% +93.96% +68.98% +6.06% +50.00% -53.19% +52.31% +33.33% +51.40% -25.69% -23.40% n/a

Revenue by Geography

Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Argentina Revenue 862K 26K 6.68M 258K 91K 1.06M 202K
Argentina Revenue Growth +3215.38% -99.61% +2489.53% +183.52% -91.45% +426.73% n/a
Canada Revenue 194K 503K 354K 7K 90K 181K 2.71M
Canada Revenue Growth -61.43% +42.09% +4957.14% -92.22% -50.28% -93.33% n/a
Germany Revenue 57K 7K 100K 722K 1.17M 1.59M n/a
Germany Revenue Growth +714.29% -93.00% -86.15% -38.18% -26.45% n/a n/a
India Revenue 7K 6M 761K n/a n/a n/a n/a
India Revenue Growth -99.88% +688.83% n/a n/a n/a n/a n/a
United States Revenue 8.84M n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 2.24M 2.68M 3.19M 3.42M 3.44M 3.81M 4.39M 4.21M 4.83M 4.65M 4.35M 6.19M 6.31M 6.37M 4.07M 4.78M 4.29M 3.67M 3.72M 3.13M 4.48M 3.15M 2.81M 3.02M 3.01M 2.95M 2.62M 2.24M 2.42M 2.94M 3.05M 3.37M 2.69M 2.76M 3.44M 2.88M 2.82M 2.79M 2.64M
Selling, General, and Administrative Revenue Growth -16.47% -15.87% -6.84% -0.58% -9.75% -13.14% +4.22% -12.84% +3.93% +6.97% -29.72% -1.96% -0.91% +56.55% -14.84% +11.32% +16.82% -1.32% +18.83% -30.02% +42.35% +11.84% -6.98% +0.40% +2.10% +12.51% +16.96% -7.20% -17.94% -3.57% -9.38% +25.34% -2.61% -19.70% +19.39% +2.13% +1.18% +5.57% n/a
Research and Development Revenue 24K 10K 272K 332K 305K 391K 359K 500K 255K 359K 395K 561K 1.04M 1.13M 1.16M 1.96M 1.76M 1.99M 2.24M 1.71M 1.93M 1.95M 1.5M 1.54M 1.33M 1.79M 1.4M 2.17M 1.75M 1.67M 1.82M 1.99M 2.25M 2.22M 2.2M 1.87M 3.18M 2.09M 1.83M
Research and Development Revenue Growth +140.00% -96.32% -18.07% +8.85% -21.99% +8.91% -28.20% +96.08% -28.97% -9.11% -29.59% -45.95% -8.22% -2.42% -40.90% +11.29% -11.59% -11.19% +31.15% -11.39% -0.97% +29.57% -2.59% +15.82% -25.64% +28.51% -35.55% +23.84% +4.79% -8.45% -8.39% -11.75% +1.76% +0.64% +17.82% -41.21% +52.40% +13.86% n/a